Dimethylbutylamine

1,3-Dimethylbutylamine

Names
Preferred IUPAC name 4-Methylpentan-2-amine
Other names (4-Methylpentan-2-yl)amine
Identifiers
CAS Number	108-09-8 Y
3D model (JSmol)	Interactive image
ChemSpider	7620
ECHA InfoCard	100.003.227
PubChem CID	7908 CID 7908
UNII	KXP599H5R6 Y
InChI InChI=1S/C6H15N/c1-5(2)4-6(3)7/h5-6H,4,7H2,1-3H3 Key: UNBMPKNTYKDYCG-UHFFFAOYSA-N InChI=1/C6H15N/c1-5(2)4-6(3)7/h5-6H,4,7H2,1-3H3 Key: UNBMPKNTYKDYCG-UHFFFAOYAT
SMILES CC(C)CC(C)N
Properties
Chemical formula	C6H15N
Molar mass	101.19 g·mol−1
Density	0.717 g/mL
Boiling point	108–110 °C (226–230 °F; 381–383 K)
Hazards
NFPA 704	3 2 0
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

1,3-Dimethylbutylamine (1,3-DMBA), or simply dimethylbutylamine (DMBA), is a stimulant drug structurally related to methylhexanamine (1,3-dimethylamylamine (1,3-DMAA)) where a butyl group replaces the amyl group. It is also known as AMP Citrate (4-amino-2-methylpentane citrate). The compound is an aliphatic amine.

DMBA has been identified as an unapproved ingredient in some over-the-counter dietary supplements, in which it is used in an apparent attempt to avoid laws prohibiting the use of methylhexanamine. The U.S. Food and Drug Administration (FDA) considers any dietary supplement containing DMBA to be "adulterated".

There are no known human safety studies on DMBA and its health effects are entirely unknown.